ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,681.20
      -2.17%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.225
      0.14%
      Bitcoin
      57,066.62
      -0.49%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Global Blood Therapeutics Inc (GBT)

      7. Global Blood Therapeutics Inc (GBT) News

      GBT

      Global Blood Therapeutics (GBT)

      Global Blood Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GBT
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      06/06/202210:00AMGlobeNewswire Inc.The GBT Foundation Opens 2022 ACCEL Grant Program to Provide Up to $500,000 in Support to Sickle Cell Disease Nonprofit Healthcare Organizations and InstitutionsNASDAQ:GBTGlobal Blood Therapeutics Inc
      06/06/20228:00AMGlobeNewswire Inc.GBT’s Inclacumab and GBT601 Receive U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for the Treatment of Sickle Cell DiseaseNASDAQ:GBTGlobal Blood Therapeutics Inc
      06/03/20225:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/02/20224:05PMGlobeNewswire Inc.GBT Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
      06/01/20224:05PMGlobeNewswire Inc.GBT to Host Investor Conference Call on Friday, June 10 and Participate in Upcoming Investor ConferencesNASDAQ:GBTGlobal Blood Therapeutics Inc
      05/12/202210:00AMGlobeNewswire Inc.GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 CongressNASDAQ:GBTGlobal Blood Therapeutics Inc
      05/08/202211:08AMTipRanksSVB Securities Thinks Global Blood Therapeutics’ Stock is Going to RecoverNASDAQ:GBTGlobal Blood Therapeutics Inc
      05/05/20224:05PMGlobeNewswire Inc.GBT Announces Participation in Upcoming Investor ConferencesNASDAQ:GBTGlobal Blood Therapeutics Inc
      05/05/20224:05PMGlobeNewswire Inc.GBT Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
      05/05/20227:06AMTipRanksGlobal Blood Therapeutics (GBT) Received its Third Buy in a RowNASDAQ:GBTGlobal Blood Therapeutics Inc
      05/05/20226:26AMTipRanksH.C. Wainwright Reaffirms Their Buy Rating on Global Blood Therapeutics (GBT)NASDAQ:GBTGlobal Blood Therapeutics Inc
      05/04/20224:22PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GBTGlobal Blood Therapeutics Inc
      05/04/20224:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      05/04/20224:05PMGlobeNewswire Inc.GBT Reports First Quarter 2022 Financial ResultsNASDAQ:GBTGlobal Blood Therapeutics Inc
      04/28/20224:17PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GBTGlobal Blood Therapeutics Inc
      04/28/20224:12PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GBTGlobal Blood Therapeutics Inc
      04/28/20228:20AMGlobeNewswire Inc.GBT Launches Inaugural Environmental, Social and Governance (ESG) ReportNASDAQ:GBTGlobal Blood Therapeutics Inc
      04/27/20228:00AMGlobeNewswire Inc.GBT to Announce First Quarter 2022 Financial Results on Wednesday, May 4, 2022NASDAQ:GBTGlobal Blood Therapeutics Inc
      04/07/20224:05PMGlobeNewswire Inc.GBT Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
      03/25/20224:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      03/24/20224:05PMGlobeNewswire Inc.GBT Announces Participation at the Guggenheim Genomic Medicines & Rare Disease DayNASDAQ:GBTGlobal Blood Therapeutics Inc
      03/18/20227:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      03/10/20224:05PMGlobeNewswire Inc.GBT Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
      03/03/20228:00AMGlobeNewswire Inc.The GBT Foundation Opens 2022 ACE Grant Program, Providing up to $250,000 in Support to Sickle Cell Disease Community-Based OrganizationsNASDAQ:GBTGlobal Blood Therapeutics Inc
      02/28/20228:00AMGlobeNewswire Inc.GBT Announces Participation in Upcoming Investor ConferencesNASDAQ:GBTGlobal Blood Therapeutics Inc
      02/23/20224:05PMGlobeNewswire Inc.GBT Reports Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:GBTGlobal Blood Therapeutics Inc
      02/16/20224:05PMGlobeNewswire Inc.GBT to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 23, 2022NASDAQ:GBTGlobal Blood Therapeutics Inc
      02/16/20226:00AMGlobeNewswire Inc.European Commission Approves Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and OlderNASDAQ:GBTGlobal Blood Therapeutics Inc
      02/14/20222:46PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GBTGlobal Blood Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GBT

      Your Recent History

      USOTC
      CLMOF
      Cliemon AB (CE)
      Delayed Upgrade Clock